A December 2025 human factors study indicated that 95 percent of participants preferred this room-temperature, self-applied system over standard injection pens, suggesting a potential adherence benefit for people who find injections uncomfortable or hard to sustain
Its a peptide, not a stimulant
The key takeaway is that preparation matters
In other words, it is possible for patients to maintain weight while stopping the medication but some patients may also gain weight at a faster rate or a greater degree than what is seen in the scientific studies, says Lofton
Once you meet your deductible, you'll typically pay a fixed percent of the drug's cost, called coinsurance, until you meet your annual spending cap, called an out of pocket maximum
Most Medicare and other insurance plans typically provide coverage for well-known GLP-1 agonists like Ozempic, Trulicity, and Victoza